ARETEIA THERAPEUTICS

Areteia Therapeutics is a clinical stage biotechnology company committed to putting respiratory patients in better control of their disease-and back in control of their lives-with the first potential oral drug for eosinophilic asthma... Areteia Therapeutics brings together seasoned drug developers with deep regulatory, commercial, and supply-chain experience-and a track record of bringing new medicines to global markets.

Also known as: Areteia Therapeutics, Inc.

Primary location: Chapel Hill United States